ArticleRenal failure2025
Paraspinous muscle sarcopenic indices for predicting mortality in patients undergoing hemodialysis.
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe examined the association between computed tomography (CT)-derived paraspinous muscle density (PSMD) and index (PSMI) and all-cause mortality in patients undergoing hemodialysis.
methodsWe included 234 hemodialysis patients and used CT images to measure PSMD and PSMI at the third lumbar vertebra level. PSMD and PSMI were determined as the average CT-based value of the paraspinous muscle in Hounsfield units (HUs) and as the paraspinous muscle area adjusted by height (cm
resultsThe PSMD and PSMI were independently associated with the C-reactive protein level and geriatric nutritional risk index, respectively. The receiver operating curve-derived sex-specific cutoffs of PSMD and PSMI for predicting mortality were 32.1 HU and 13.29 cm
conclusionsPSMD may be better than PSMI for predicting all-cause mortality risk in patients undergoing hemodialysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.